Barhemsys Injection, Solution
Product Images NDC 71390-125
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Barhemsys (NDC 71390-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Acacia Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (2 mL Vial Carton)
This is a prescription drug with the NDC code 71390-125-21 called Barhemsys. It is administered through injection at a concentration of 25mg/ml with a single-use sterile vial. Any unused portion must be discarded, and it should only be given through intravenous infusion. The vial has a LOT number, but the expiration date is not available in the given text.*
Barhemsys 03
Barhemsys is a medication available in single-dose vials for intravenous infusion only. Each 2mL vial contains 5mg of the active ingredient amisupriode. The solution is clear and colorless, supplied in a protective carton. The medication should be stored at temperatures between 20°C and 25°C and used within 12 hours of removal from its protective carton. The recommended dosage should be followed as per the prescribing information. Barhemsys is manufactured by Acacia Pharma and is a sterile, non-pyrogenic solution.*
Barhemsys 04
This is a description of Barhemsys' injection, with the NDC code 71390-125-51, containing 10mg per 4ml of solution. It comes in a single-dose sterile vial and should be used for intravenous infusion only. Any unused portion should be discarded. The lot number is 222706, and there is an expiration date, but it is not provided in the text.*
Barhemsys 05
Barhemsys is a sterile and non-pyrogenic injection available in a single-dose vial for intravenous administration. The solution is colorless and clear and each 4 mL vial contains 10 mg of amisulpride, 374mg of dicloxacillin monohydrate, and 7.2mg of sodium dihydrate. This solution also contains sodium hydroxide and sodium hydroxide to adjust the pH level between 4.75 to 5.20. The solution should be protected from the light and stored between 20 to 25°C. Any unused portion should be discarded after 12 hours of exposure to air and must be administered only by prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.